Zhejiang Ausun Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -48.53% vs 110.29% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -76.01% vs 226.41% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "158.90",
          "val2": "308.70",
          "chgp": "-48.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.70",
          "val2": "146.00",
          "chgp": "-88.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "2.80",
          "chgp": "-7.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "29.50",
          "val2": "-3.00",
          "chgp": "1,083.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23.20",
          "val2": "96.70",
          "chgp": "-76.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-28.70%",
          "val2": "404.20%",
          "chgp": "-43.29%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -0.38% vs -2.93% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -36.85% vs -18.55% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "786.80",
          "val2": "789.80",
          "chgp": "-0.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "187.00",
          "val2": "243.20",
          "chgp": "-23.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "8.40",
          "val2": "8.00",
          "chgp": "5.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "5.50",
          "chgp": "-109.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "130.60",
          "val2": "206.80",
          "chgp": "-36.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "143.40%",
          "val2": "227.40%",
          "chgp": "-8.40%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

158.90

308.70

-48.53%

Operating Profit (PBDIT) excl Other Income

16.70

146.00

-88.56%

Interest

2.60

2.80

-7.14%

Exceptional Items

29.50

-3.00

1,083.33%

Consolidate Net Profit

23.20

96.70

-76.01%

Operating Profit Margin (Excl OI)

-28.70%

404.20%

-43.29%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is -48.53% vs 110.29% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -76.01% vs 226.41% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

786.80

789.80

-0.38%

Operating Profit (PBDIT) excl Other Income

187.00

243.20

-23.11%

Interest

8.40

8.00

5.00%

Exceptional Items

-0.50

5.50

-109.09%

Consolidate Net Profit

130.60

206.80

-36.85%

Operating Profit Margin (Excl OI)

143.40%

227.40%

-8.40%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -0.38% vs -2.93% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -36.85% vs -18.55% in Dec 2024

All Annual Results